Br Med J (Clin Res Ed) 290(6466): 428-432
Epidemiological characteristics of platelet aggregability.
Abstract
The epidemiological characteristics of platelet aggregability were established in 958 participants in the Northwick Park Heart Study. The main analyses were based on the dose of adenosine diphosphate at which primary aggregation occurred at half its maximum velocity. Aggregability increased with age in both sexes, was greater in whites than blacks (particularly among men), and tended to decrease with the level of habitual alcohol consumption. Aggregability was, however, greater in women than men and in nonsmokers than smokers. There was no relation between aggregability on the one hand and obesity, current or past oral contraceptive use, menopausal state, or blood cholesterol and triglyceride concentrations on the other. Aggregability was somewhat, though not significantly, higher in men with a history of ischaemic heart disease and in those with electrocardiographic evidence of ischaemia than in those without. There was a strong association between the plasma fibrinogen concentration and aggregability. The widely held concept of platelet aggregability and its implications is probably an oversimplification. In the prevention of thrombosis it may be as useful to consider modifying external influences on platelet behaviour, such as plasma fibrinogen concentration or thrombin production, as it is to rely solely on platelet active agents.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1001K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BORN GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. [PubMed] [Google Scholar]
- Meade TW, North WR, Chakrabarti R, Haines AP, Stirling Y. Population-based distributions of haemostatic variables. Br Med Bull. 1977 Sep;33(3):283–288. [PubMed] [Google Scholar]
- Meade TW, North WR, Chakrabarti R, Stirling Y, Haines AP, Thompson SG, Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. [PubMed] [Google Scholar]
- Meade TW, Brozović M, Chakrabarth R, Howarth DJ, North WR, Stirling Y. An epidemiological study of the haemostatic and other effects of oral contraceptives. Br J Haematol. 1976 Nov;34(3):353–364. [PubMed] [Google Scholar]
- Slack J, Noble N, Meade TW, North WR. Lipid and lipoprotein concentrations in 1604 men and women in working populations in north-west London. Br Med J. 1977 Aug 6;2(6083):353–357.[PMC free article] [PubMed] [Google Scholar]
- Meade TW, Chakrabarti R, Haines AP, North WR, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J. 1979 Jan 20;1(6157):153–156.[PMC free article] [PubMed] [Google Scholar]
- Thompson SG. A method of analysis of laboratory data in an epidemiological study where time trends are present. Stat Med. 1983 Apr-Jun;2(2):147–153. [PubMed] [Google Scholar]
- Zawilska KM, Born GV, Begent NA. Effect of ADP-utilizing enzymes on the arterial bleeding time in rats and rabbits. Br J Haematol. 1982 Feb;50(2):317–325. [PubMed] [Google Scholar]
- Saniabadi AR, Lowe GD, Barbenel JC, Forbes CD. A comparison of spontaneous platelet aggregation in whole blood with platelet rich plasma: additional evidence for the role of ADP. Thromb Haemost. 1984 Feb 28;51(1):115–118. [PubMed] [Google Scholar]
- Johnson M, Ramey E, Ramwell PW. Sex and age differences in human platelet aggregation. Nature. 1975 Jan 31;253(5490):355–357. [PubMed] [Google Scholar]
- Coppe D, Wessinger SJ, Ransil BJ, Harris W, Salzman E. Sex differences in the platelet response to aspirin. Thromb Res. 1981 Jul 1;23(1-2):1–21. [PubMed] [Google Scholar]
- Nenci GG, Agnelli G, Parise P, Merante F, Ballatori E. Sex difference in circulating platelet aggregates and response to antiplatelet treatment. Thromb Haemost. 1982 Dec 27;48(3):341–341. [PubMed] [Google Scholar]
- Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, DeSanctis RW. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med. 1977 Dec 8;297(23):1246–1249. [PubMed] [Google Scholar]
- Hawkins RI. Smoking, platelets and thrombosis. Nature. 1972 Apr 28;236(5348):450–452. [PubMed] [Google Scholar]
- Levine PH. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation. 1973 Sep;48(3):619–623. [PubMed] [Google Scholar]
- Belch JJ, McArdle BM, Burns P, Lowe GD, Forbes CD. The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers. Thromb Haemost. 1984 Feb 28;51(1):6–8. [PubMed] [Google Scholar]
- Haut MJ, Cowan DH. The effect of ethanol on hemostatic properties of human blood platelets. Am J Med. 1974 Jan;56(1):22–33. [PubMed] [Google Scholar]
- Fenn CG, Littleton JM. Interactions between ethanol and dietary fat in determining human platelet function. Thromb Haemost. 1984 Feb 28;51(1):50–53. [PubMed] [Google Scholar]
- Marmot MG. Alcohol and coronary heart disease. Int J Epidemiol. 1984 Jun;13(2):160–167. [PubMed] [Google Scholar]
- Fox SC, Burgess-Wilson M, Heptinstall S, Mitchell JR. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter. Thromb Haemost. 1982 Dec 27;48(3):327–329. [PubMed] [Google Scholar]
- Harbury CB, Hershgold JE, Schrier SL. Requirements for aggregation of washed human platelets suspended in buffered salt solutions. Thromb Diath Haemorrh. 1972 Aug 31;28(1):2–13. [PubMed] [Google Scholar]
- Tollefsen DM, Majerus PW. Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments. J Clin Invest. 1975 Jun;55(6):1259–1268.[PMC free article] [PubMed] [Google Scholar]
- Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. [PubMed] [Google Scholar]
- Lowe GD, Reavey MM, Johnston RV, Forbes CD, Prentice CR. Increased platelet aggregates in vascular and nonvascular illness: correlation with plasma fibrinogen and effect of ancrod. Thromb Res. 1979 Feb-Mar;14(2-3):377–386. [PubMed] [Google Scholar]
- Carvalho AC, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med. 1974 Feb 21;290(8):434–438. [PubMed] [Google Scholar]
- Lowe GD, Drummond MM, Third JL, Bremner WF, Forbes CD, Prentice CR, Lawrie TD. Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia. Thromb Haemost. 1980 Feb 29;42(5):1503–1507. [PubMed] [Google Scholar]
- Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J. 1973 Dec 8;4(5892):576–581.[PMC free article] [PubMed] [Google Scholar]